LLA Therapy Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Akron, OH USA
Total Funding:N/A
Founded:1986
Lead Investor(s):N/A

Estimated Revenue & Financials

  • LLA Therapy's estimated annual revenue is currently $13.8M per year.
  • LLA Therapy's estimated revenue per employee is $270,000

Employee Data

  • LLA Therapy has 51 Employees.
  • LLA Therapy grew their employee count by 19% last year.
  • LLA Therapy currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Orthopedic Foot...
$13.8M514%N/A-N/A
Hopewell Health...
$23M8531%N/A-N/A
DECA HEALTH, IN...
$9.2M3410%N/A-N/A
LLA Therapy
$13.8M5119%N/A-N/A
Apex Dermatolog...
$9.2M3442%N/A-N/A
Juvly Aesthetic...
$16.7M6235%N/A-N/A
Rinkov Eyecare ...
$10.3M389%N/A-N/A
Cleveland Clini...
$6.5M24N/AN/A-N/A
LasikPlus
N/A327N/AN/A-N/A
Groups: recover...
$39.7M1478%N/A-N/A
Missing a competitor? Contribute!?
Submit

For over 25 years, LLA Therapy has thrived in Northeast Ohio. A dynamic, full-service therapy company, LLA Therapy brings quality care to children and adults in three offices, and partners with area schools, and companies. In 2011 owner Troy McClowry acquired PRN Therapy, bringing a new facet to LLA, further expanding the footprint. LLA Therapy has grown to a staff of over 75 employees, while still maintaining the values that have made this company a vital part of the local community. LLA Therapy's mission is to set the standard for state of the art clinical and ethical therapy services in all venues serviced by our clinicians. Our work improves the lives of our clients and their families, supports the professional growth of clinicians, and creates a nurturing, supportive atmosphere.

keywords:N/A

51

Number of Employees

$13.8M

Revenue (est)

1

Current Jobs

19%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

LLA Therapy News

24-Aug-19 - BioInvent's Partner Oxurion NV has Reported Topline Month 3 ...

... partner Oxurion NV has today reported topline data from a Phase lla ... Combination therapy did not show increase in best corrected visual ...

24-Aug-19 - Recon: Philips Under Investigation for Graft in Brazil; Pfizer ...

Pfizer invests $500 million in expanding gene therapy facility ... BioInvent Will Conduct Phase l/lla Trial With BI-1206 in Combination With ...

12-Sep-19 - Home Medical Equipment Market Sales Revenue to Significantly Increase in the Next Few Years

... and monitoring products, therapeutic products, mobility care products. ... AstraZeneca, Baxter, ResMed, Stryker, and Sunrise Medical LLA.